[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

An overview: management of patients with advanced hepatocellular carcinoma

J Wang, R Wu, J Sun, F Lei, H Tan, X Lu - BioScience Trends, 2022 - jstage.jst.go.jp
Hepatocellular carcinoma (HCC) has constituted a significant health burden worldwide, and
patients with advanced HCC, which is stage C as defined by the Barcelona Clinic Liver …

[HTML][HTML] LAG3 blockade coordinates with microwave ablation to promote CD8+ T cell-mediated anti-tumor immunity

D Shao, Y Chen, H Huang, Y Liu, J Chen, D Zhu… - Journal of Translational …, 2022 - Springer
Background The immune checkpoint inhibitors (ICIs) combined with other therapeutic
strategies have shown exciting results in various malignancies, and ICIs have now become …

[HTML][HTML] Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis

HI Kim, J An, S Han, JH Shim - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Methods We searched databases for randomized trials assessing the efficacy of loco-
regional treatments for HCCs≤ 5 cm with no extrahepatic spread or portal invasion. The …

[HTML][HTML] Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes

JH Yoon, SK Choi - Journal of Liver Cancer, 2023 - synapse.koreamed.org
Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Local-regional treatment of hepatocellular carcinoma: A primer for radiologists

N Horvat, AI De Oliveira, B Clemente de Oliveira… - Radiographics, 2022 - pubs.rsna.org
The treatment planning for patients with hepatocellular carcinoma (HCC) relies
predominantly on tumor burden, clinical performance, and liver function test results. Curative …

[HTML][HTML] Update on percutaneous local ablative procedures for the treatment of hepatocellular carcinoma

L Luerken, M Haimerl, M Doppler… - RöFo-Fortschritte auf …, 2022 - thieme-connect.com
Hintergrund Das hepatozelluläre Karzinom (HCC) ist das fünfthäufigste Tumorleiden
weltweit. Da viele HCCs bereits zum Zeitpunkt der Erstdiagnose nicht resektabel sind …

[HTML][HTML] Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1highCD11b+ cells elimination …

J Tan, T Liu, W Fan, J Wei, B Zhu, Y Liu, L Liu… - … Pharmaceutica Sinica B, 2023 - Elsevier
Cryoablation (CRA) and microwave ablation (MWA) are two main local treatments for
hepatocellular carcinoma (HCC). However, which one is more curative and suitable for …

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

JW Park - Clinical and Molecular Hepatology (대한간학회지), 2022 - kiss.kstudy.com
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

[HTML][HTML] Liver-directed treatment options following liver tumor recurrence: a review of the literature

CT Aquina, MF Eskander, TM Pawlik - Frontiers in Oncology, 2022 - frontiersin.org
Recurrence following curative-intent hepatectomy for colorectal cancer liver metastasis,
hepatocellular carcinoma, or cholangiocarcinoma is unfortunately common with a reported …